In­gre­di­ent man­u­fac­tur­er Cen­taur gets FDA warn­ing over records, sub­stan­dard clean­ing

Ac­tive phar­ma­ceu­ti­cal in­gre­di­ent mak­er Cen­taur Phar­ma­ceu­ti­cals re­ceived a warn­ing let­ter from the FDA in ear­ly June over sev­er­al is­sues at its man­u­fac­tur­ing site in the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER